BNP Paribas SA (BNP)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 87.04 |
|---|---|
| 52-week range | 65.17 – 113.94 |
| Return, 1 month / 3 months | −12.3% / −16.4% |
| Return, 1 year / 3 years | +33.8% / +98.9% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 27.2% |
| Worst drawdown (1 year) | -24.1% |
| Average daily value traded | 0.92M EUR |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BNP Paribas is a French banking group based in Paris. It serves individual customers, small businesses, large companies and institutional clients through retail banking, corporate and investment banking, and asset management. Its retail networks take deposits and provide loans and payment services, while its corporate and investment arm offers financing, advisory work and trading in financial markets. The group also provides insurance, wealth management and securities services to clients in Europe and other regions.
The shares are listed on the Deutsche Börse Xetra in Germany under the code BNP, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BNP Paribas SA (BNP) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 87.04 on 27 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 226 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.8% and over the last three months it fell 16.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.0% | ||
| From 52-week high | -22.8% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -16.4% | ||
| 6-month return | 2.7% | ||
| 12-month return, skipping the last month | 52.6% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.1% | ||
| Liquidity | 70 · Strong | Trades actively. | |
| Average daily value traded | 0.92M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −12.3% |
| 3 months | −16.4% |
| 6 months | +2.7% |
| 1 year | +33.8% |
| 3 years | +98.9% |
| 5 years | +116.1% |
Signals
| 50-day / 200-day average | 95.60 / 91.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Sep 2026 | EUR 3.2300 |
| 18 May 2026 | EUR 2.5700 |
| 26 Sep 2025 | EUR 2.5900 |
| 19 May 2025 | EUR 4.7900 |
| 21 May 2024 | EUR 4.6000 |
| 22 May 2023 | EUR 3.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.